Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on specific liver imaging standards used by liver disease specialists.
- People whose general physical functioning is rated at a level indicating they are fully active or have only minor limitations in physically demanding activity (confirm with trial site).
- People whose liver function falls within a certain acceptable range, as measured by a standard liver health scoring system called Child-Pugh A or B (confirm with trial site).
- People whose bilirubin level (a substance measured in blood related to liver function) is below 2.5 mg/dL.
- People whose creatinine level (a substance measured in blood related to kidney function) is below 2.0 mg/dL.
- People who have not previously received any treatment directed at the liver or any whole-body treatment for their liver cancer.
- People with a single liver tumour that cannot be surgically removed and measures 3 centimetres or smaller.
- People whose albumin level (a protein measured in blood) was below 3.4 g/dL at the time of their liver cancer diagnosis.
- People whose tumour location in the liver is suitable for two specific treatment procedures used in this trial (confirm with trial site).
Who may not be able to join:
- People who are pregnant.
- People who have another active cancer at the same time as their liver cancer diagnosis.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ari Cohen, MD, Ochsner Health
Phone: 5048421936
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.